Treatment Considerations for Prostate Cancer Progressing After Combination Therapy for mCSPC

ASCO20 Virtual education the treatment considerations for patients who received combination therapy for metastatic castration sensitive prostate cancer (mCSPC), the role of chemotherapy and novel androgen axis inhibitors in patients with mCSPC.

Read the full article here

Related Articles